中文产业新闻评分50Chinese source
诺和诺德与恒瑞医药就口服GLP-1/GIP双重激动剂HRS-1596达成26亿美元许可协议
26亿美元！诺和诺德牵手恒瑞，股价直线拉涨
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
26亿美元！诺和诺德牵手恒瑞，股价直线拉涨
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.